MyAverix Finance
US · Healthcare
Endurance RP Limited (RPGLF)
Drug Manufacturers - Specialty & Generic
Endurance RP Limited (RPGLF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RPGLF
Endurance RP Limited (RPGLF) — FAQ
What is RPGLF's P/E ratio?
The price-to-earnings (P/E) ratio for Endurance RP Limited (RPGLF) is 18.00 (data as of 2026-05-23).
Does Endurance RP Limited pay a dividend?
Dividend yield is not available in the current snapshot for Endurance RP Limited (RPGLF). Check the MyAverix Finance app for the latest dividend data.
What sector is Endurance RP Limited in?
Endurance RP Limited (RPGLF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is RPGLF listed on?
RPGLF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.